Opal Capital LLC Has $9.45 Million Stock Position in UnitedHealth Group Incorporated $UNH

Opal Capital LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 196.6% in the first quarter, HoldingsChannel.com reports. The firm owned 34,927 shares of the healthcare conglomerate’s stock after purchasing an additional 23,152 shares during the quarter. UnitedHealth Group accounts for approximately 1.7% of Opal Capital LLC’s portfolio, making the stock its 11th biggest holding. Opal Capital LLC’s holdings in UnitedHealth Group were worth $9,451,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of UNH. ADAR1 Capital Management LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $1,489,000. Sunbelt Securities Inc. increased its holdings in UnitedHealth Group by 283.4% in the first quarter. Sunbelt Securities Inc. now owns 5,429 shares of the healthcare conglomerate’s stock worth $1,469,000 after purchasing an additional 4,013 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 2.2% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,550 shares of the healthcare conglomerate’s stock worth $1,502,000 after buying an additional 120 shares during the period. Rock Springs Capital Management LP lifted its position in shares of UnitedHealth Group by 29.9% during the 1st quarter. Rock Springs Capital Management LP now owns 53,000 shares of the healthcare conglomerate’s stock valued at $14,341,000 after acquiring an additional 12,200 shares during the period. Finally, Empowered Funds LLC grew its holdings in UnitedHealth Group by 36.9% in the first quarter. Empowered Funds LLC now owns 115,284 shares of the healthcare conglomerate’s stock worth $31,195,000 after purchasing an additional 31,053 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Major Q2 earnings beat supports the rally. UnitedHealth reported adjusted earnings of $6.38 per share versus the $4.94 consensus estimate, while revenue reached $112.03 billion, above expectations of $110.81 billion. Management maintained 2026 adjusted EPS guidance of $19.50 to $20.00, reinforcing confidence in the recovery. What’s next for UnitedHealth after its major Q2 earnings beat
• Positive Sentiment: Improved medical costs and conservative guidance are encouraging investors. The company’s improved medical loss ratio helped results, and some investors view the cautious outlook as a buffer against future volatility. However, part of the margin improvement came from exiting unprofitable markets rather than broad-based operating gains. UnitedHealth Group Stock Opinions on Q2 Earnings Beat
• Positive Sentiment: The stock’s rebound after Berkshire Hathaway’s exit is being viewed favorably. Commentary noting that Berkshire likely sold too early highlights renewed investor confidence in UNH, though it does not change the company’s fundamentals. UnitedHealth Stock Has Rallied Big Since Berkshire Bailed
• Neutral Sentiment: Medicare Part D pricing creates both opportunity and risk. The planned expiration of federal subsidies could lead to higher premiums for stand-alone Medicare drug plans next year. Higher pricing may support insurers’ revenue, but it could also reduce affordability and enrollment, creating uncertainty for UnitedHealth’s Medicare business. Why Prices Could Rise for Medicare Drug Plans Next Year
• Negative Sentiment: Medicaid pressure and questions about earnings durability remain risks. Analysts have noted that market exits contributed to the better medical loss ratio, while Medicaid challenges and the stock’s rapid advance could limit additional near-term upside. UnitedHealth Pulls Back Post 52-Week High

UnitedHealth Group Price Performance

UNH opened at $428.94 on Wednesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80. The firm’s fifty day moving average price is $409.32 and its two-hundred day moving average price is $346.72. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $461.62. The company has a market capitalization of $389.54 billion, a price-to-earnings ratio of 27.60, a P/E/G ratio of 1.45 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the prior year, the firm posted $4.08 EPS. The firm’s quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a $2.32 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. UnitedHealth Group’s payout ratio is presently 59.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Barclays increased their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. UBS Group upped their target price on UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Truist Financial lifted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a report on Thursday, July 16th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $455.92.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.